SCHEMBL3147793

SCHEMBL3147793

CCOC(C)OOOC(C)OCC

nearest known ligand 0.65

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.65
THRB P10828 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3147805 0.87 LMNA (0.73) LMNATHRB
SCHEMBL1229104 0.81
SCHEMBL9459 0.79
SCHEMBL2094168 0.79 LMNA (1.00) LMNATHRB
SCHEMBL8909577 0.79
SCHEMBL6551991 0.77 LMNA (0.36) LMNA
SCHEMBL2416296 0.77 LMNA (0.44) LMNA
SCHEMBL5105333 0.76
SCHEMBL3453066 0.76
SCHEMBL9518993 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4088536-A ALKYLATING LITHIUM CYCLOPENTADIENE, OXYGENATING TO PRODUCE HYDROXYCLYCLOPENTENONES, SEPARATION, MULTISTAGE WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 1978-05-09 US claimed
EP-1169467-B1 PROCESS FOR THE PREPARATION OF PROSTAGLANDIN PRECURSORS CHIROTECH TECHNOLOGY LTD (GB) 2010-02-17 EP disclosed
US-20040195108-A1 Method of producing oxocylohexyl or oxocyclohexylene derivatives BOTZEM JORG (DE) 2004-10-07 US disclosed
EP-1169467-A1 PROCESS FOR THE PREPARATION OF PROSTAGLANDIN PRECURSORS Chirotech Technology Limited (GB) 2002-01-09 EP disclosed
US-20010009770-A1 Process for the preparation of prostaglandin precursors FOX MARTIN EDWARD (GB) 2001-07-26 US disclosed
US-6214611-B1 PREPARATION OF A PROPARGYLIC ALCOHOL ENRICHED IN (R)-ENANTIOMER BY ESTERIFICATION OF RACEMIC ALCOHOL USING ACYL DONOR AND ENZYME, REMOVAL OF UNTREATED (S)-ALCOHOL, AND ENANTIOSELECTIVE HYDROLYSIS OF (R)-ESTER USING SECOND ENZYME CHIROTECH TECHNOLOGY LIMITED (GB) 2001-04-10 US disclosed
WO-2000061777-A1 PROCESS FOR THE PREPARATION OF PROSTAGLANDIN PRECURSORS CHIROTECH TECHNOLOGY LIMITED (GB) 2000-10-19 WO disclosed
EP-0043479-A1 Novel cyclopentenone derivatives and methods for the preparation of the novel compounds AMERICAN CYANAMID COMPANY (US) 1982-01-13 EP disclosed
EP-0013107-A1 16-Hydroxy-16-vinyl (or cyclopropyl)-prostan-1-ols and pharmaceutical compositions containing the same AMERICAN CYANAMID COMPANY (US) 1980-07-09 EP disclosed
US-4206151-A BRONCHODILATOR, ANTISECRETORY, HYPOTENSIVE AMERICAN CYANAMID COMPANY (US) 1980-06-03 US disclosed
US-4142056-A MULTISTAGE PROCESS FOR PREPARING 2-(6'-CARBOMETHOXYHEXYL)-2-CYCLOPENTEN-1-ONE WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 1979-02-27 US disclosed
US-4088536-A ALKYLATING LITHIUM CYCLOPENTADIENE, OXYGENATING TO PRODUCE HYDROXYCLYCLOPENTENONES, SEPARATION, MULTISTAGE WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 1978-05-09 US disclosed
US-4031129-A LITHIUM CYCLOPENTADIENE, ETHYL-7-BROMOHEPTANOATE WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 1977-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010009770-A1 Process for the preparation of prostaglandin precursors ADH1A, ADH1C, ADH5 LMNA 2426/4885THRB 1937/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.